跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVETIRACETAM IV ARX levetiracetam 500mg/5mL concentrate solution for IV infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
LEVETIRACETAM IV ARX levetiracetam 500mg/5mL concentrate solution for IV infusion vial
Approved
STANDARD
LEVETIRACETAM IV ARX levetiracetam 500mg/5mL concentrate solution for IV infusion vial
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
01a7e6dc88f0443f
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
01a7e6dc88f0443f
Product Name
LEVETIRACETAM IV ARX levetiracetam 500mg/5mL concentrate solution for IV infusion vial
Artg Id
222092
Artg Name
LEVETIRACETAM IV ARX levetiracetam 500mg/5mL concentrate solution for IV infusion vial
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2015-03-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8012e624c161b72960cc9066fcc2472f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/7914fc6f555ca140a05ef9bc8573f5ba.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
01a7e6dc88f0443f
Type
Standard
Back to TGA Approvals